Authors: YUROVSKY VV WEERSINK EJM MELTZER SS MOORE WC POSTMA DS BLEECKER ER WHITE B

Citation: Vv. Yurovsky et al., T-CELL REPERTOIRE IN THE BLOOD AND LUNGS OF ATOPIC ASTHMATICS BEFORE AND AFTER RAGWEED CHALLENGE, American journal of respiratory cell and molecular biology, 18(3), 1998, pp. 370-383

Authors: MELTZER SS HASDAY JD COHN J BLEECKER ER

Citation: Ss. Meltzer et al., INHIBITION OF EXERCISE-INDUCED BRONCHOSPASM BY ZILEUTON - A 5-LIPOXYGENASE INHIBITOR, American journal of respiratory and critical care medicine, 153(3), 1996, pp. 931-935

Authors: WISNIEWSKI PL BUSSE WW MELTZER SS WILLIAMS J SHANNON T SORKNESS C BLEECKER ER

Citation: Pl. Wisniewski et al., BRONCHODILATORY EFFECTS OF BAYX7195, A SELECTIVE LEUKOTRIENE RECEPTORANTAGONIST, Journal of allergy and clinical immunology, 95(1), 1995, pp. 300-300

Authors: HASDAY JD MCCREA KA MELTZER SS BLEEKER ER

Citation: Jd. Hasday et al., DYSREGULATION OF AIRWAY CYTOKINE EXPRESSION IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE AND ASTHMA, American journal of respiratory and critical care medicine, 150(5), 1994, pp. 190000054-190000058

Authors: MELTZER SS JOHNS MA RECHSTEINER EA JUNGERWIRTH S DAMICO JM BLEECKER ER

Citation: Ss. Meltzer et al., BRONCHODILATORY EFFECTS OF BAY1005, A 5-LIPOXYGENASE INHIBITOR, IN MILD-TO-MODERATE ASTHMA, Journal of allergy and clinical immunology, 93(1), 1994, pp. 294-294

Authors: BLEECKER ER MELTZER SS

Citation: Er. Bleecker et Ss. Meltzer, BETA-AGONISTS AND ASTHMA - HOW DO NEW DEVELOPMENTS AFFECT TRADITIONALTHERAPY, The Journal of asthma, 30(3), 1993, pp. 149-154